Skip to main content

Series A Life Science Companies

Explore 234 life science startups that raised series a funding. Access verified founder contact information and fundraising data.

Total Companies
234
Total Funding
$864.3M
Avg Funding
$34.6M
Cities
21

Export 234 Series A Life Science Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Boston, United States
$225.0M
raised

Solstice Oncology develops immuno-oncology therapies focused on treating and preventing cancer through targeted approaches.

Sep 2026
Series A

Founder Contacts

41,000+ verified contacts

Westport, United States
$40.0M
raised

Alphina Therapeutics is a biotechnology company that aims to leverage proprietary biomarkers and breakthrough insights for cancer patients.

Sep 2021
Series A

Founder Contacts

41,000+ verified contacts

Singapore, Singapore
$10.0M
raised

Neuroglee Therapeutics is a digital therapeutic platform created to treat patients in the early stages of the disease.

Sep 2021
Series A

Founder Contacts

41,000+ verified contacts

Seattle, United States
$116.0M
raised

BrainChild Bio develops chimeric antigen receptor T-cell therapies engineered to treat tumors of the central nervous system.

Sep 2026
Series A

Founder Contacts

41,000+ verified contacts

Perth, Australia
$1.5M
raised

Lixa develops revolutionary, scalable solutions for antimicrobial resistance (AMR) and the US$5T per annum biofilm problem.

Sep 2022
Series A

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 234 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Burlington, United States
$32.0M
raised

Epion is developing a minimally invasive treatment for an ectatic corneal disease.

Sep 2022
Series A

Founder Contacts

41,000+ verified contacts

Boston, United States
$24.1M
raised

Seeker Biologics aims to make new medicines for allergic, autoimmune and inflammatory diseases.

Sep 2021
Series A

Founder Contacts

41,000+ verified contacts

Pittsburgh, United States
$48.0M
raised

ai3Bio develops treatments to transform the lives of patients with cancer.

Sep 2026
Series A

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$30.0M
raised

Form Bio is a platform for data management, workflows, and data visualisation.

Sep 2022
Series A

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$16.0M
raised

Elucidata delivers ML-ready biomedical molecular data that is curated to accelerate drug discovery.

Sep 2022
Series A

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 234 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Tübingen, Germany
$13.7M
raised

ViferaXS is a clinical-stage biotechnology company developing peptide-based cancer immunotherapies.

Sep 2026
Series A

Founder Contacts

41,000+ verified contacts

New York, United States
$30.1M
raised

Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers.

Sep 2025
Series A

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$56.3M
raised

Typewriter Therapeutics develops mRNA-based gene therapies using a gene writing platform for site-specific insertion of therapeutic genes.

Sep 2026
Series A

Founder Contacts

41,000+ verified contacts

Durham, United States
$25.0M
raised

Ramona develops high-throughput microscopy tools to unlock previously impossible experiments within the modern biology lab.

Sep 2026
Series A

Founder Contacts

41,000+ verified contacts

Toronto, Canada
$25.0M
raised

Altis is accelerating clinical trials with AI endpoints so that drug developers can get the best new treatment to patients sooner.

Sep 2026
Series A

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 234 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Hong Kong, Hong Kong
$5.0M
raised

Connexus Therapeutics is a private, venture-backed biotechnology startup.

Sep 2026
Series A

Founder Contacts

41,000+ verified contacts

Geleen, The Netherlands
$16.0M
raised

Matisse Pharmaceuticals is a biopharmaceutical company developing therapies for sepsis and septic shock by targeting cytotoxic histones.

Sep 2026
Series A

Founder Contacts

41,000+ verified contacts

Minneapolis, United States
$5.5M
raised

Evia Bio is a life sciences innovation company that develops non-DMSO cryopreservation solutions.

Sep 2026
Series A

Founder Contacts

41,000+ verified contacts

Boston, United States
$50.0M
raised

AllRock Bio is a drug developing firm that offers novel therapies to patients suffering hypertension and other fibrotic conditions.

Sep 2025
Series A

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$20.0M
raised

Mithrl is a software development company that builds the custom workflows for NGS data on-demand.

Sep 2026
Series A

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 234 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Emeryville, United States
$44.0M
raised

RegCell develops cell therapies designed to restore immune tolerance in autoimmune diseases.

Sep 2026
Series A

Founder Contacts

41,000+ verified contacts

Tokyo, Japan

Cogsmart is a healthcare company that provides data science services for brain science and medical evidence.

Sep 2023
Series A

Founder Contacts

41,000+ verified contacts

Liège, Belgium
$9.6M
raised

Amyl Therapeutics is a preclinical biotechnology company developing immunotherapy for neurodegenerative diseases.

Sep 2026
Series A

Founder Contacts

41,000+ verified contacts

London, United Kingdom
$8.8M
raised

Puraffinity develops precision materials to target chemicals, with an initial focus on PFAS in water

Sep 2024
Series A

Founder Contacts

41,000+ verified contacts

Palo Alto, United States
$12.8M
raised

Ganymede is a low-code PaaS for biotech software engineering that enables users to connect apps, ingest data, and construct pipelines.

Aug 2022
Series A

Founder Contacts

41,000+ verified contacts

Showing 1 to 25 of 234 companies

Ready to Connect with Series A Life Science Startups?

Get verified founder emails, funding details, and company data for 234 series a life science companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked